Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-24 @ 7:22 PM
NCT ID:
NCT00081003
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Significant family history or prior atypical biopsy indicative of a moderate or high risk of developing breast cancer
* No concurrent inflammatory breast cancer
* Hormone receptor status:
* Not specified
PATIENT CHARACTERISTICS:
Age
* 18 to 64
Sex
* Female
Menopausal Status
* Premenopausal or postmenopausal
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* No prior allergy to EMLA cream or lidocaine
* No severe illness that would preclude study participation
* No mental illness or handicap that would preclude study compliance
* No concurrent active infection or inflammation in the breast being studied
* Not unconscious
* Not pregnant
* No nursing within the past 12 months
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* Not specified
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* No prior subareolar surgery (e.g., microdochectomy or major duct excision) that may disrupt the ductal systems within 2 cm of the nipple
* No prior breast implantation on proposed lavage side
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT00081003
Study Brief:
Protocol Section:
NCT00081003